Effect of calcium supplementation on bone dynamics of the maxilla, mandible and proximal tibia in experimental osteoporosis.
The effect of calcium supplementation on the bone dynamics in the hard palate of the molar region (maxilla), mandible and proximal tibia in experimental osteoporotic rats was examined. Ninety ovariectomized (OVX) and 45 sham-OVX Wistar female rats were used in this study. All the rats received surgical operation at 6 weeks of age. Ovariectomized rats were fed on a low calcium diet (0.02%) for 12 weeks post-operation, and then randomly divided into the two following groups. One group was fed on high calcium diet (2.30%) (OVX-HCa) and the other group was remained on the low calcium diet (OVX-LCa). Sham-OVX rats were fed on regular calcium diet (1.15%) during the experimental period (Sham-OVX). Histomorphological analysis was carried out from 12 to 32 weeks post-operation. On undecalcified thin section, bone volume, eroded surface, osteoid surface and bone formation rate were calculated for cortical bone of the maxilla, and for cancellous bone of the mandible and proximal tibia. In the OVX-LCa group, compared with the Sham-OVX group, decrease of the bone volume and increase of the bone resorption and formation parameters were detected throughout the observation periods. In the OVX-HCa group, compared with the OVX-LCa group, increase of the bone volume and temporarily increased parameters of bone formation at 1 week after feeding on high calcium diet were observed in the maxilla, but these changes were not observed in the mandible and proximal tibia. Moreover, the bone resorption and formation parameters in the maxilla, mandible and proximal tibia in the OVX-HCa group became equivalent to the Sham-OVX levels with the passage of time.
Shirai
H
H
Department of Removable Prosthodontics, Okayama University Dental School, 2-5-1 Shikata-cho, Okayama City 700-8525, Japan. hajime_s@md.okayama-u.ac.jp
Sato
T
T
Oka
M
M
Hara
T
T
Mori
S
S
D000704:Analysis of Variance; D000818:Animals; D001835:Body Weight; D001857:Bone Matrix / Q000187:drug effects / Q000473:pathology; D001862:Bone Resorption / Q000473:pathology; D002136:Calcium, Dietary / Q000008:administration & dosage / Q000627:therapeutic use*; D019587:Dietary Supplements; D004195:Disease Models, Animal; D005260:Female; D005452:Fluoresceins; D005456:Fluorescent Dyes; D007091:Image Processing, Computer-Assisted; D008334:Mandible / Q000187:drug effects* / Q000473:pathology; D008437:Maxilla / Q000187:drug effects* / Q000473:pathology; D010012:Osteogenesis / Q000187:drug effects; D010024:Osteoporosis / Q000178:diet therapy*; D010052:Ovariectomy; D021362:Palate, Hard / Q000187:drug effects / Q000473:pathology; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D013223:Statistics as Topic; D013752:Tetracycline; D013977:Tibia / Q000187:drug effects* / Q000473:pathology
D002136:Calcium, Dietary; D005452:Fluoresceins; D005456:Fluorescent Dyes; D013752:Tetracycline; C007740:fluorexon